Rance, Karen https://orcid.org/0009-0004-2682-7281
Young, Brenda
McCreary, Gretchen
Williams, Stephanie
Urrutia-Pereira, Marilyn
Willard, Kristen
Mustafa, Ghulam
Parikh, Purvi
Winders, Tonya
Tal-Singer, Ruth
Funding for this research was provided by:
AstraZeneca (95531573)
Article History
Received: 6 July 2025
Accepted: 14 August 2025
First Online: 6 October 2025
Declarations
:
: Karen Rance, Brenda Young, Gretchen McCreary, Stephanie Williams, Kristen Willard, and Ghulam Mustafa, as well as Marilyn Urrutia Pereira, have no disclosures to report. Purvi Parikh is a speaker for Genentech. Tonya Winders is a paid advisor and speaker for AstraZeneca, Chiesi, GSK, Novartis, Roche, and Sanofi Regeneron. Ruth Tal-Singer is a shareholder of GSK and holds share options in ENA Respiratory and reports personal fees from AstraZeneca, Boehringer Ingelheim, ENA Respiratory, Janssen, Roche, Vocalis Health, Teva, ImmunoMet, Renovion, Samay Health, GSK, ItayAndBeyond, COPD Foundation, and GlobalSkin.
: The United States-based research team received an exemption for the English version of the survey, recruitment text, images, and consent form from a central institutional review board (BRANY, Lake Success, NY), granted an exempt determination for the English version of the survey, recruitment text, images. No incentives were provided for survey participation. The study adhered to the ethical principles outlined in the Declaration of Helsinki and followed the Consensus-Based Checklist for Reporting of Survey Studies (CROSS) []. The survey was administered electronically and included a mix of multiple-choice, Likert scale, and open-ended questions to gather both quantitative and qualitative data. All participants provided electronic consent prior to beginning the survey, during which the study’s purpose, procedures, and other relevant details were clearly explained. Participation was voluntary, with the option to withdraw any time.